Risk

GettyImages/Waldemarus

BIOPRODUCTION CONGRESS DUBLIN 2017

HPRA tells drug makers how to get ‘GMP inspection-ready’

By Flora Southey

Firms should identify risks prior to inspection, make staff available during regulator visits, and respond promptly post-inspection when undergoing GMP site checks, says Ireland’s Health Products Regulatory Authority (HPRA).

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers